Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kshitis Chandra Baral"'
Autor:
Jae Geun Song, Kshitis Chandra Baral, Gyu-Lin Kim, Ji-Won Park, Soo-Hwa Seo, Da-Hyun Kim, Dong Hoon Jung, Nonye Linda Ifekpolugo, Hyo-Kyung Han
Publikováno v:
Drug Delivery, Vol 30, Iss 1 (2023)
AbstractPharmaceutical application of therapeutic proteins has been continuously expanded for the treatment of various diseases. Efficient and reliable bioanalytical methods are essential to expedite the identification and successful clinical develop
Externí odkaz:
https://doaj.org/article/ab698c29d679437badc5fcbb68e358a5
Publikováno v:
Pharmaceutics, Vol 15, Iss 12, p 2720 (2023)
MT-102 is a new anti-inflammatory agent derived from Juglans mandshurica and Isatis indigotica. Its therapeutic potential is hindered by low aqueous solubility, impacting its in vivo efficacy. Therefore, this study aimed to develop a self-microemulsi
Externí odkaz:
https://doaj.org/article/813d476040d44299af71256a13db1716
Autor:
Kshitis Chandra Baral, Jae-Geun Song, Sang Hoon Lee, Rajiv Bajracharya, Godesi Sreenivasulu, Minkyoung Kim, Kyeong Lee, Hyo-Kyung Han
Publikováno v:
Pharmaceutics, Vol 13, Iss 8, p 1142 (2021)
AC1497 is an effective dual inhibitor of malate dehydrogenase 1 and 2 targeting cancer metabolism. However, its poor aqueous solubility results in low bioavailability, limiting its clinical development. This study was conducted to develop an effectiv
Externí odkaz:
https://doaj.org/article/fc543c62f2b846f6baeba4a59a00f363
Publikováno v:
International Journal of Nanomedicine
Probiotics have demonstrated their high potential to treat and/or prevent various diseases including neurodegenerative disorders, cancers, cardiovascular diseases, and inflammatory diseases. Probiotics are also effective against multidrug-resistant p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c036e167bf9174a61a926c2ea20c3c64
https://doi.org/10.2147/ijn.s337427
https://doi.org/10.2147/ijn.s337427
Publikováno v:
Malaysian Journal of Pharmaceutical Sciences. 18:31-59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e2368d7aaf614404d67fca2a5b3cbed
https://doi.org/10.21315/mjps2020.18.1.3
https://doi.org/10.21315/mjps2020.18.1.3
Autor:
Rajiv Bajracharya, Jae Geun Song, Kshitis Chandra Baral, Hyo-Kyung Han, Kyeong Lee, Minkyoung Kim, Godesi Sreenivasulu, Sang Hoon Lee
Publikováno v:
Pharmaceutics
Volume 13
Issue 8
Pharmaceutics, Vol 13, Iss 1142, p 1142 (2021)
Volume 13
Issue 8
Pharmaceutics, Vol 13, Iss 1142, p 1142 (2021)
AC1497 is an effective dual inhibitor of malate dehydrogenase 1 and 2 targeting cancer metabolism. However, its poor aqueous solubility results in low bioavailability, limiting its clinical development. This study was conducted to develop an effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c723ecee41b4d5be76c2e6b06b673a20